Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-28
2010-11-16
Weddington, Kevin (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S866000
Reexamination Certificate
active
07834050
ABSTRACT:
Compounds of Formula I are describedalong with pharmaceutical formulations thereof, and methods of treating disorders such as diabetes and neurodegenerative diseases with such compounds.
REFERENCES:
patent: 6051597 (2000-04-01), Zhang et al.
patent: 6596760 (2003-07-01), Chen et al.
patent: 7244743 (2007-07-01), Weber et al.
patent: 7247616 (2007-07-01), Ohsumi et al.
patent: 7304081 (2007-12-01), Yao et al.
patent: 7312196 (2007-12-01), L'Italien et al.
patent: 7345049 (2008-03-01), Sagi et al.
patent: 7427622 (2008-09-01), Zhao et al.
patent: 7432306 (2008-10-01), Kitahara et al.
patent: 7442833 (2008-10-01), Eaddy, III et al.
patent: 7446121 (2008-11-01), Pfefferkorn
patent: 7456174 (2008-11-01), Nettekoven et al.
patent: 7459446 (2008-12-01), Baker et al.
patent: 7713951 (2010-05-01), DeLuca et al.
patent: WO 2004-050014 (2004-05-01), None
Salituro et al, “Discovery of a Small Molecule Insulin Receptor Activator,” Recent Progress in Hormone Research, vol. 56, pp. 107-126 (2001).
Barrett, T.G., et al, “Difficult Diabetes in Teenagers,” Current Pediatrics, vol. 16, pp. 106-110 (2006).
Deng, L, Synthesis of Analogues of DAQ B1 as Potential Anti-Diabetic Drugs, Dissertation (Mar. 31, 2005), Department of Chemistry, Duke University, Durham, NC, pp. 99-112, 173-183.
Fleisher D et al. Improved oral drug delivery: solubility limitations overcome by the use of prodrugs. Advanced Drug Delivery Reviews. 1996; 19: 115-130.
Gomes P et al. Cyclization-activated prodrugs. Molecules. 2007; 12: 2484-2506.
Duke University
Myers Bigel Sibley & Sajovec P.A.
Weddington Kevin
LandOfFree
Small molecule insulin mimetics absent quinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Small molecule insulin mimetics absent quinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small molecule insulin mimetics absent quinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4245721